Enter your information below and we'll overnight a comprehensive information packet FREE of charge.

First Name:

Last Name:

Telephone:

Email:

Address:

City:

State:

Zip:
Have you or someone you know been diagnosed with mesothelioma?
Yes No

UK woman dies following battle with mesothelioma cancer

An English man has lost his wife of 60 years to an asbestos-related illness. Tony Boxall lost his wife Evelyn to mesothelioma, a rare form of cancer, earlier this year. It is believed she was exposed to asbestos while soldering valves on aircraft radios as a teenager.

Mesothelioma affects thousands of new patients each year, and while there are palliative treatment methods available, including chemotherapy, there is no known cure. The cancer may lie dormant for many decades before the first symptoms emerge. Unfortunately, the majority of patients lose their battle with this form cancer less than two years following diagnosis.

"We knew exactly what it was. She was working when she was 16. We got married when she was 21. The trouble is it laid dormant for so long. The way it grows is much like fungi," Boxall told reporters. "From last August she started to get out of breath and we found out she had fluid on her lung."

It is unfortunately not uncommon for people to develop mesothelioma or other asbestos illnesses decades after their initial exposure to asbestos materials. Those who worked with asbestos long before the health risks associated with it were recognized, like Evelyn Boxall, probably handled the carcinogen without ever knowing that it may one day cause them to develop cancer.

Mr. Boxall tearfully recalled the last time she was at home. "I remember when the nurses came to the house to take her to the hospice and she knew it was the last time she would be at the house. She asked the nurses to take her to the conservatory. I said to her ‘why do you want to go out there, ducky?’ She said to me ‘because I want to say goodbye to my lovely garden’. It broke my heart seeing her like that. I loved her very much and I miss her tremendously."

Thank you for visiting this website which is created for the benefit of the general public. This website and its content are produced and sponsored by the law firm of James F. Early, LLC (James F. Early, Esq.). All of the information is intended as a resource available at no cost to people diagnosed with mesothelioma and their loved ones. Nonetheless, it may be considered attorney advertising. The content contained herein was not prepared by medical professionals and it is not intended, nor should it be considered, as a substitute for medical advice. The information provided on this website is intended as educational material, designed solely to support, and not replace, the relationship that exists between a patient/site visitor and his/her healthcare professional. Additionally, neither visiting this website nor viewing its content is intended, and shall not be considered, to create an attorney-client relationship. An attorney-client relationship can only be created by mutual agreement and consent of the prospective client and the attorney. Neither the transmission nor receipt of this website material creates an attorney-client relationship between sender and receiver. The material contained herein is general in nature and may not apply to your particular factual or legal circumstances. Online readers should not act on this information without seeking professional counsel and advice. All information on this website is provided as a resource for the convenience and benefit of visitors to this website and their families. No affiliation with or endorsement of: (1) this website by the persons, facilities or organizations listed herein; OR (2) such persons, facilities or organizations by this website, is intended, nor should it be inferred. In all cases and without exception, such visitors and their families, for their own particular situation, must perform their own investigation of the suitability and appropriateness of any such person, facility or organization. Please read our disclaimer for more information.